Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells

Biochemical and Biophysical Research Communications

Volumn 357, Issue 2, 2007, Pages 397-401

  Suuronen, Tiina ^a   Nuutinen, Tapio ^a   Ryhänen, Tuomas ^a   Kaarniranta, Kai ^a   Salminen, Antero ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

5 Aza 2 deoxycytidine; HDAC; Histone deacetylase inhibitor; Macular degeneration; Trichostatin A; Valproate

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTICONVULSIVE AGENT; CLUSTERIN; HISTONE DEACETYLASE INHIBITOR; PROTEIN; TRICHOSTATIN A; VALPROIC ACID;

ANGIOGENESIS; ARTICLE; DNA METHYLATION; EPIGENETICS; HUMAN; HUMAN CELL; INFLAMMATION; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA MACULA AGE RELATED DEGENERATION; TRANSCRIPTION INITIATION;

CELLS, CULTURED; CLUSTERIN; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; PIGMENT EPITHELIUM OF EYE; TRANS-ACTIVATION (GENETICS);

EID: 34247118445     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.135     Document Type: Article

References (31)

1. Rosenberg M.E., and Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 27 (1995) 633-645
2. Wilson M.R., and Easterbrook-Smith S.B. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 3 (2000) 95-98
3. Jones S.E., and Jomary C. Clusterin. Int. J. Biochem. Cell Biol. 34 (2002) 427-431
4. Trougakos I.P., and Gonos E.S. Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34 (2002) 1430-1448
5. Jenne D.E., Lowin B., Peitsch M.C., Bottcher A., Schmitz G., and Tschopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J. Biol. Chem. 266 (1991) 11030-11036
6. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., and Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 99 (2002) 14619-14621
7. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20 (2001) 705-732
8. Anderson D.H., Mullins R.F., Hageman G.S., and Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134 (2002) 411-431
9. Matsubara E., Frangione B., and Ghiso J. Characterization of apolipoprotein J-Alzheimer's A beta interactions. J. Biol. Chem. 270 (1995) 7563-7567
10. Zenkel M., Kruse F.E., Junemann A.G., Naumann G.O., and Schlotzer-Schrehardt U. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1982-1990
11. Trougakos I.P., and Gonos E.S. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic. Res. 40 (2006) 1324-1334
12. Michel D., Chatelain G., North S., and Brun G. Stress-induced transcription of the clusterin/apoJ gene. Biochem. J. 328 (1997) 45-50
13. Rosemblit N., and Chen C.L. Regulators for the rat clusterin gene: DNA methylation and cis-acting regulatory elements. J. Mol. Endocrinol. 13 (1994) 69-76
14. Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene 278 (2001) 25-31
15. Göttlicher M., Minucci S., Zhu P., Krämer O.H., Schimpf A., Giavara S., Sleeman J.P., Coco F.L., Nervi C., Pelicci P.G., and Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20 (2001) 6969-6978
16. Michaelis M., Michaelis U.R., Fleming I., Suhan T., Cinatl J., Blaheta R.A., Hoffmann K., Kotchetkov R., Busse R., Nau H., and Cinatl Jr. J. Valproic acid inhibits angiogenesis in vitro and in vivo. Mol. Pharmacol. 65 (2004) 520-527
17. Nuutinen T., Suuronen T., Kyrylenko S., Huuskonen J., and Salminen A. Induction of clusterin/apo J expression by histone deacetylase inhibitors in neural cells. Neurochem. Int. 47 (2005) 528-538
18. Kyrylenko S., Kyrylenko O., Suuronen T., and Salminen A. Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases. Cell. Mol. Life Sci. 60 (2003) 1990-1997
19. Kuusisto E., Suuronen T., and Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem. Biophys. Res. Commun. 280 (2001) 223-228
20. Yoshida M., Horinouchi S., and Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17 (1995) 423-430
21. Bressler N.M., Bressler S.B., and Fine S.L. Age-related macular degeneration. Surv. Ophthalmol. 32 (1988) 375-413
22. Amin S., Chong N.H.V., Bailey T.A., Zhang J., Knupp C., Cheetham M.E., Greenwood J., and Luthert P.J. Modulation of sub-RPE deposits in vitro: a potential model for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1281-1288
23. An E., Lu X., Flippin J., Devaney J.M., Halligan B., Hoffman E., Csaky K., and Hathout Y. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J. Proteome Res. 5 (2006) 2599-2610
24. Lu Q., Qiu X., Hu N., Wen H., Su Y., and Richardson B.C. Epigenetics, disease, and Therapeutic interventions. Ageing Res. Rev. 5 (2006) 449-467
25. Tschopp J., and French L.E. Clusterin: modulation of complement function. Clin. Exp. Immunol. 97 Suppl. 2 (1994) 11-14
26. Donoso L.A., Kim D., Frost A., Callahan A., and Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 51 (2006) 137-152
27. Hellebrekers D.M., Griffoen A.W., and Van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim. Biophys. Acta 1775 (2007) 76-91
28. Sivamurthy N., Stone H.H., LoGerfo F.W., and Quist W.C. Apolipoprotein J inhibits the migration and adhesion of endothelial cells. Surgery 130 (2001) 204-209
29. Jackson J.K., Gleave M.E., Gleave J., and Burt H.M. The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis 8 (2005) 229-238
30. Bartl M.M., Luckenbach T., Bergner O., Ullrich O., and Koch-Brandt C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp. Cell. Res. 271 (2001) 130-141
31. Yoo C.B., and Jones P.A. Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 5 (2006) 37-50